RMD
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

ResMed Inc. is a digital health company that designs and manufactures cloud-connected medical devices and software solutions for sleep and breathing health disorders. The company operates in two segments: Sleep and Breathing Health, which includes CPAP systems for obstructive sleep apnea, ventilators, diagnostic products, and mask systems; and Residential Care Software, which provides care management platforms for senior living and home health providers. ResMed serves patients, healthcare professionals, and residential care facilities globally. Key subsidiaries and acquired businesses include Noctrix Health for restless legs syndrome treatment, VirtuOx for independent diagnostic testing, Brightree for durable medical equipment workflow automation, and MEDIFOX DAN for care management in Germany. The company was formed in 1989 and commercialized the first successful non-invasive CPAP treatment for obstructive sleep apnea.

Summarised from the company's own disclosures, fiscal year ended Aug 2026

Industry Medical Devices Homepage resmed.com
Sector Healthcare IR page —
Tags
sleep apnea, cpap therapy, respiratory care, home healthcare, digital health, cloud-connected devices, residential care software, diagnostic testing, chronic disease management, medical devices, AirFit 20 Series, Noctrix Health, VirtuOx, Brightree, MEDIFOX DAN, MatrixCare, Healthcare First, Citus
Press page —

Metrics

Valuation  
Market cap $ 33.331B
Market cap (USD) $ 33.331B
P/E 21.58
PEG 1.12
P/BV 5.60
P/S 5.81
P/OCF 18.82
P/FCF 20.72
Dividend yield 1.0%
Turnover / mcap —
Returns  
ROE 24.3%
ROI 21.8%
ROIC 21.4%
Profit margin 26.9%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 19.3%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity 4.2%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 53
Quality score 47.4%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2016 FY 2015 FY 2014 FY 2011 FY 2010
Revenue 772.216M 667.516M 565.187M 1.243B 1.092B
Net profit 352.409M 352.886M 345.273M — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Statement of changes in beneficial ownership Bull 0 Bear 0 Routine
Statement of changes in beneficial ownership Bull 0 Bear 0 Routine

Prompts

ResMed Inc. (ticker RMD), listed in United States.

ETFs Holding ResMed Inc.

ETF Weight in ETF Shares Market value As of
LGHT 9.11% 1,156 $ 225.281K Jun 30, 2026
CWS 4.04% 18,814 $ 4.475M Nov 17, 2026
SEIQ 2.04% 69,334 $ 13.512M Jun 30, 2026
FGSI 1.95% 167 $ 39.835K Nov 11, 2026
RUNN 1.88% 32,577 $ 7.822M Aug 31, 2026
RDVI 1.53% 250,021 $ 59.638M Nov 11, 2026
XOVR 1.36% 152,376 $ 29.695M Jun 30, 2026
QIDX 1.26% 2,325 $ 490.529K Jul 31, 2026
ROE 1.10% 11,464 $ 2.73M Nov 18, 2026
WLTG 1.04% 3,788 $ 799.192K Jul 31, 2026
PY 0.76% 8,575 $ 1.671M Jun 30, 2026
DSTL 0.67% 73,123 $ 14.25M Jun 30, 2026
GQQQ 0.62% 4,283 $ 1.02M Nov 18, 2026
IALT 0.57% 188,884 $ 44.99M Nov 16, 2026
BAMV 0.44% 2,131 $ 511.653K Aug 31, 2026
AVMC 0.36% 8,303 $ 1.978M Nov 16, 2026
PHEQ 0.28% 2,012 $ 392.099K Jun 30, 2026
BDVL 0.26% 19,225 $ 4.579M Nov 16, 2026
JSTC 0.26% 3,246 $ 773.165K Nov 17, 2026
TACU 0.25% 193 $ 45.971K Nov 17, 2026
DFLV 0.23% 73,384 $ 17.531M Nov 12, 2026
DAK 0.22% 384 $ 90K Nov 18, 2026
CLSE short -0.22% -8,122 $ -1.95M Aug 31, 2026
AIVL 0.21% 4,405 $ 858.446K Jun 30, 2026
SOVF 0.20% 838 $ 176.801K Jul 31, 2026
AFLG 0.20% 7,611 $ 1.813M Nov 16, 2026
SFGV 0.19% 9,005 $ 2.14M Nov 18, 2026
TIER 0.14% 225 $ 47.471K Jul 31, 2026
CAPE 0.13% 1,571 $ 306.156K Jun 30, 2026
DFVX 0.12% 3,011 $ 719.298K Nov 12, 2026
GQI 0.12% 1,627 $ 317.07K Jun 30, 2026
AVUQ 0.12% 2,153 $ 512.823K Nov 16, 2026
GSPY 0.12% 3,583 $ 853.435K Nov 17, 2026
DFUV 0.11% 74,325 $ 17.755M Nov 12, 2026
DFSU 0.11% 10,903 $ 2.605M Nov 12, 2026
GVLU 0.09% 1,038 $ 247.241K Nov 17, 2026
XMAG 0.08% 684 $ 163.401K Nov 13, 2026
THEQ 0.07% 112 $ 26.677K Nov 17, 2026
VSLU 0.06% 1,699 $ 331.101K Jun 30, 2026
MODL 0.06% 3,168 $ 617.38K Jun 30, 2026
DFAU 0.06% 30,974 $ 7.399M Nov 12, 2026
DXUV 0.06% 14,494 $ 3.462M Nov 12, 2026
FLSP 0.05% 2,535 $ 494.021K Jun 30, 2026
AVLC 0.05% 3,348 $ 797.46K Nov 16, 2026
DFAC 0.05% 182,205 $ 43.527M Nov 12, 2026
DFUS 0.05% 43,821 $ 10.468M Nov 12, 2026
DCOR 0.04% 83,956 $ 20.056M Nov 12, 2026
VOXP 0.04% 12 $ 2,531.76 Jul 31, 2026
GDE 0.04% 849 $ 203.845K Aug 31, 2026
AVUS 0.04% 26,148 $ 6.228M Nov 16, 2026
AVSU 0.04% 804 $ 191.505K Nov 16, 2026
APUE 0.04% 4,009 $ 962.561K Aug 31, 2026
HCMT 0.04% 1,007 $ 212.457K Jul 31, 2026
NTSX 0.04% 2,529 $ 492.852K Jun 30, 2026
MSLC 0.03% 5,633 $ 1.352M Aug 31, 2026
ACVF 0.03% 230 $ 48.525K Jul 31, 2026
NTSD 0.02% 40 $ 7,795.20 Jun 30, 2026
CSHP 0.02% 291 $ 69.313K Nov 16, 2026
EBI 0.01% 159 $ 38.176K Aug 31, 2026
CORO 0.00% 91 $ 21.67K Nov 16, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
RMD canonical Common share — US nyse 237.00 USD 2026-11-17
RMD Common share — AU asx — —